These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia. Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924 [TBL] [Abstract][Full Text] [Related]
3. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies. Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805 [TBL] [Abstract][Full Text] [Related]
5. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726 [TBL] [Abstract][Full Text] [Related]
6. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470 [TBL] [Abstract][Full Text] [Related]
7. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672 [TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226 [TBL] [Abstract][Full Text] [Related]
9. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation. Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913 [TBL] [Abstract][Full Text] [Related]
10. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. Visentin GP; Ford SE; Scott JP; Aster RH J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825 [TBL] [Abstract][Full Text] [Related]
11. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633 [TBL] [Abstract][Full Text] [Related]
12. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin. Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107 [TBL] [Abstract][Full Text] [Related]
13. Atomic description of the immune complex involved in heparin-induced thrombocytopenia. Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia. Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384 [TBL] [Abstract][Full Text] [Related]
15. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4. Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975 [TBL] [Abstract][Full Text] [Related]
17. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia. Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397 [TBL] [Abstract][Full Text] [Related]
18. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia. Madeeva D; Cines DB; Poncz M; Rauova L Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857 [TBL] [Abstract][Full Text] [Related]
19. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin. Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]